Mohammad A. Shahshahan

Mohammad Shahshahan practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Mohammad Shahshahan's NPI, 1588018402, was assigned on April 17, 2016. Mohammad Shahshahan holds California license 20A15820.

Mohammad Shahshahan's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Mohammad Shahshahan's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Mohammad Shahshahan is also affiliated with Cedars-Sinai Marina Hospital. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Mohammad Shahshahan to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mohammad Shahshahan practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Mohammad Shahshahan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Mohammad Shahshahan is licensed in California.

CMS data shows 868 Medicare services from Mohammad Shahshahan across 4 procedure codes in 2024, for 270 Medicare patients. Medicare paid $83,316 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 270 Medicare patients who saw Mohammad Shahshahan in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mohammad Shahshahan's median patient age at 66, with 47% women.

In 2024, Mohammad Shahshahan wrote 231 Medicare Part D claims for 90 patients. 85% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $780 in total drug cost. In 2023, CMS named 279 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Mohammad Shahshahan for performance year 2024, reported as part of a group. Mohammad Shahshahan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Mohammad Shahshahan from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $47. It also lists 1 research payment totaling $500 in 2024.